Hepatocellular carcinoma risk assessment using gadoxetic acid-enhanced hepatocyte phase magnetic resonance imaging.
Komatsu N, Motosugi U, Maekawa S, Shindo K, Sakamoto M, Sato M, Tatsumi A, Miura M, Amemiya F, Nakayama Y, Inoue T, Fukasawa M, Uetake T, Ohtaka M, Sato T, Asahina Y, Kurosaki M, Izumi N, Ichikawa T, Araki T, Enomoto N.
Komatsu N, et al.
Hepatol Res. 2014 Dec;44(13):1339-46. doi: 10.1111/hepr.12309. Epub 2014 Apr 24.
Hepatol Res. 2014.
PMID: 24528803